NICOMALOM 1  : Tablet - Steris Healthcare PVT LTD………

NICOMALOM 1 

Nicoumalone (1mg)

NICOMALOM 1, is a medication known for its role in anticoagulant therapy. In this article, we'll explore the intricacies of Nicoumalone (1mg), elucidating its mechanism of action, therapeutic indications, dosage recommendations, potential side effects, and more. Whether you're a healthcare professional seeking insights or an individual navigating treatment options, this guide aims to equip you with all the essential information about NICOMALOM 1.

Understanding NICOMALOM 1: NICOMALOM 1 contains Nicoumalone in a dosage of 1mg and belongs to the class of medications known as vitamin K antagonists. Nicoumalone exerts its anticoagulant effects by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver, thereby preventing the formation of blood clots. This mechanism makes NICOMALOM 1 a valuable tool in the prevention and treatment of thromboembolic disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

Indications and Usage: The primary indications for NICOMALOM 1 include the prevention and treatment of venous thromboembolism (VTE), including DVT and PE. Additionally, NICOMALOM 1 may be prescribed for the prevention of stroke and systemic embolism in patients with atrial fibrillation or prosthetic heart valves. It's essential to use NICOMALOM 1 under the guidance of a qualified healthcare professional, as part of a comprehensive anticoagulation regimen.

Dosage: NICOMALOM 1 is typically administered orally at a dosage of 1mg once daily, with or without food. The dosage may be adjusted based on individual patient factors, including age, weight, renal function, and the presence of concurrent medications. Regular monitoring of coagulation parameters, such as prothrombin time (PT) and international normalized ratio (INR), is essential to ensure therapeutic efficacy and minimize the risk of bleeding complications.

Potential Side Effects: While NICOMALOM 1 is generally well-tolerated, it may cause certain side effects in some individuals. Common adverse reactions may include bleeding, bruising, gastrointestinal upset, skin rash, and liver dysfunction. In rare cases, more serious side effects such as hemorrhagic stroke or allergic reactions may occur. Patients should promptly report any unusual or concerning symptoms to their healthcare provider for further evaluation.

Contraindications and Precautions: NICOMALOM 1 is contraindicated in individuals with a known hypersensitivity to Nicoumalone or any of its components. Caution should be exercised when prescribing NICOMALOM 1 to patients with a history of bleeding disorders, peptic ulcer disease, or severe renal impairment. Concurrent use of other medications that affect coagulation, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or antiplatelet agents, should be carefully monitored to minimize the risk of bleeding complications.

Interactions: NICOMALOM 1 may interact with certain medications, including other anticoagulants, antiplatelet agents, and drugs that affect liver enzyme activity. Healthcare professionals should review patients' medication profiles carefully and adjust treatment regimens accordingly to minimize the risk of drug interactions. Patients should inform their healthcare provider about all medications, supplements, and herbal products they are taking before starting NICOMALOM 1.

Conclusion: In conclusion, NICOMALOM 1, featuring Nicoumalone (1mg), plays a crucial role in anticoagulant therapy for the prevention and treatment of thromboembolic disorders. By understanding its mechanism of action, indications, dosage recommendations, potential side effects, and contraindications, healthcare providers can make informed decisions regarding its use. When integrated into a comprehensive treatment plan that addresses individual patient needs and risk factors, NICOMALOM 1 can significantly reduce the risk of thromboembolic events and improve overall patient outcomes. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW